Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00633880Phase 3Completed
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Roy Freeman, MD

Harvard Medicine School

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Collaborated on 1 trial
Similarity Score44%

Horacio Kaufmann, MD

NYU Langone Health

Moderately Similar
6 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Collaborated on 1 trial
Similarity Score44%

Phillip A Low, MD

Mayo Foundation

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Collaborated on 1 trial
Similarity Score44%

Alvin McElveen, MD

Bradenton Neurology, Inc

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Similarity Score30%

Brent Goodman, MD

Mayo Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Similarity Score30%

Stephen Greer, MD

Arkansas Cardiology

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Similarity Score30%

Alberto Vasquez, MD

Suncoast Neuroscience

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Similarity Score30%

Richard Hull, MD

North Alabama Neuroscience

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Similarity Score30%

Horacio Kaufmann Kaufmann, MD

NYU School of Medicine

Related
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase Deficiency

Worked with same sponsors:

Chelsea Therapeutics
Similarity Score8%

Horacio Kaufmann, M.D.

NYU Langone Medical Center

Related
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase Deficiency

Worked with same sponsors:

Chelsea Therapeutics
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00633880Phase 3PrincipalInvestigator

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more
Completed

All 1 trials loaded